Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Steins · SciRah

Researcher profile · Semantic Scholar

M. Steins

Share profile

M. Steins — researcher profile on SciRah

h-index: 28
Works: 70
Citations: 21K

Most-cited papers

Nivolumab versus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer
H. Borghaei, L. Paz-Ares, L. Horn, D. Spigel +24 more
2015New England Journal of Medicine8,408 citations Open access
Semantic Scholar
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
J. Brahmer, K. Reckamp, P. Baas, L. Crinò +21 more
2015New England Journal of Medicine7,912 citations Open access
Semantic Scholar
First-Line Nivolumab in Stage IV or Recurrent Non-Small-Cell Lung Cancer
D. Carbone, M. Reck, L. Paz-Ares, B. Creelan +25 more
2017New England Journal of Medicine1,394 citations Open access
Semantic Scholar
Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057).
L. Horn, D. Spigel, E. Vokes, E. Holgado +25 more
2017Journal of Clinical Oncology795 citations Open access
Semantic Scholar
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases
E. Vokes, N. Ready, E. Felip, L. Horn +22 more
2018Annals of Oncology446 citations Open access
Semantic Scholar
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 antibody therapy.
T. Eigentler, J. Hassel, C. Berking, J. Aberle +9 more
2016Cancer Treatment Reviews386 citations
Semantic Scholar
Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer.
J. von Pawel, R. Jotte, D. Spigel, M. O'Brien +15 more
2014Journal of Clinical Oncology314 citations
Semantic Scholar
Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer
G. Goeckenjan, H. Sitter, M. Thomas, D. Branscheid +80 more
2010Pneumologie209 citations Open access
Semantic Scholar
Phase III, randomized trial (CheckMate 057) of nivolumab (NIVO) versus docetaxel (DOC) in advanced non-squamous cell (non-SQ) non-small cell lung cancer (NSCLC).
L. Paz-Ares, L. Horn, H. Borghaei, D. Spigel +16 more
2015Journal of Clinical Oncology152 citations
Semantic Scholar
Randomized phase II study of erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung cancer.
S. Ramalingam, D. Spigel, David J. Chen, M. Steins +10 more
2011Journal of Clinical Oncology131 citations Open access
Semantic Scholar
NSCLC, metastaticCheckMate 026: A phase 3 trial of nivolumab vs investigator's choice (IC) of platinum-based doublet chemotherapy (PT-DC) as first-line therapy for stage iv/recurrent programmed death ligand 1 (PD-L1)−positive NSCLC
M. Socinski, B. Creelan, L. Horn, M. Reck +16 more
2016130 citations Open access
Semantic Scholar
Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms
G. Goeckenjan, H. Sitter, M. Thomas, D. Branscheid +80 more
2011Pneumologie114 citations Open access
Semantic Scholar
Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients
Johanna Nattenmüller, Raoul Wochner, T. Muley, M. Steins +6 more
2017PLoS ONE109 citations Open access
Semantic Scholar
Efficacy and safety of thalidomide in patients with acute myeloid leukemia.
M. Steins, T. Padró, R. Bieker, Sandra Ruiz +6 more
2002Blood89 citations Open access
Semantic Scholar
Overexpression of basic fibroblast growth factor and autocrine stimulation in acute myeloid leukemia.
R. Bieker, T. Padró, J. Kramer, M. Steins +6 more
2003Cancer Research69 citations
Semantic Scholar
Overexpression of urokinase receptor and cell surface urokinase-type plasminogen activator in the human vessel wall with different types of atherosclerotic lesions
M. Steins, T. Padró, C. Schwaenen, Sandra Ruiz +3 more
2004Blood Coagulation and Fibrinolysis61 citations
Semantic Scholar
Randomized phase III trial of amrubicin versus topotecan (Topo) as second-line treatment for small cell lung cancer (SCLC).
R. Jotte, J. von Pawel, D. Spigel, M. Socinski +16 more
2011Journal of Clinical Oncology59 citations
Semantic Scholar
Correlation of EGFR mutations with chromosomal alterations and expression of EGFR, ErbB3 and VEGF in tumor samples of lung adenocarcinoma patients.
N. Reinmuth, A. Jauch, E. C. Xu, T. Muley +11 more
2008Lung Cancer51 citations
Semantic Scholar
OA03.05 Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab vs Docetaxel in CheckMate 057
S. Peters, F. Cappuzzo, L. Horn, L. Paz-Ares +13 more
201749 citations Open access
Semantic Scholar
Outcome and prognostic factors of multimodal therapy for pulmonary large-cell neuroendocrine carcinomas
J. Rieber, J. Schmitt, A. Warth, T. Muley +9 more
2015European Journal of Medical Research45 citations Open access
Semantic Scholar
Outcome and prognostic factors in patients with brain metastases from small-cell lung cancer treated with whole brain radiotherapy
D. Bernhardt, S. Adeberg, F. Bozorgmehr, Nils Opfermann +10 more
2017Journal of Neuro-Oncology40 citations
Semantic Scholar
Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation.
D. Bernhardt, F. Bozorgmehr, S. Adeberg, Nils Opfermann +9 more
2016Lung Cancer36 citations Open access
Semantic Scholar
Nivolumab (nivo) vs docetaxel (doc) in patients (pts) with advanced NSCLC: CheckMate 017/057 2-y update and exploratory cytokine profile analyses.
H. Borghaei, J. Brahmer, L. Horn, N. Ready +16 more
201636 citations
Semantic Scholar
Carboplatin/etoposide induces remission of metastasised malignant peripheral nerve tumours (malignant schwannoma) refractory to first-line therapy.
M. Steins, H. Serve, M. Zühlsdorf, N. Senninger +2 more
2002Oncology Report34 citations
Semantic Scholar
Impact of inflammatory markers on survival in patients with limited disease small-cell lung cancer undergoing chemoradiotherapy
D. Bernhardt, Sophie Aufderstrasse, L. König, S. Adeberg +10 more
2018Cancer Management and Research33 citations Open access
Semantic Scholar
Whole brain radiation therapy alone versus radiosurgery for patients with 1–10 brain metastases from small cell lung cancer (ENCEPHALON Trial): study protocol for a randomized controlled trial
D. Bernhardt, A. Hommertgen, D. Schmitt, R. El Shafie +14 more
2018Trials30 citations Open access
Semantic Scholar
Outcome and prognostic factors in single brain metastases from small-cell lung cancer
D. Bernhardt, S. Adeberg, F. Bozorgmehr, Nils Opfermann +11 more
2018Strahlentherapie und Onkologie (Print)29 citations
Semantic Scholar
POSITIVE study: physical exercise program in non-operable lung cancer patients undergoing palliative treatment
J. Wiskemann, S. Hummler, C. Diepold, Melanie Keil +6 more
2016BMC Cancer29 citations Open access
Semantic Scholar
P2.35: Nivolumab vs Docetaxel in Advanced NSCLC: CheckMate 017/057 2-Y Update and Exploratory Cytokine Profile Analysis: Track: Immunotherapy.
H. Borghaei, J. Brahmer, L. Horn, N. Ready +17 more
2016Journal of Thoracic Oncology28 citations Open access
Semantic Scholar
Re-irradiation in locally recurrent lung cancer patients
I. Schlampp, J. Rieber, S. Adeberg, F. Bozorgmehr +7 more
2019Strahlentherapie und Onkologie (Print)22 citations
Semantic Scholar
Long-term outcomes with nivolumab (Nivo) vs docetaxel (Doc) in patients (Pts) with advanced (Adv) NSCLC: CheckMate 017 and CheckMate 057 2-y update
F. Barlesi, M. Steins, L. Horn, N. Ready +16 more
201620 citations Open access
Semantic Scholar
Downregulation of neuropilin‐1 in patients with acute myeloid leukemia treated with thalidomide
M. Kreuter, M. Steins, K. Woelke, T. Buechner +2 more
2007European Journal of Haematology20 citations
Semantic Scholar
Molecular determinants of response to RTK‐targeting agents in nonsmall cell lung cancer
N. Reinmuth, M. Meister, T. Muley, M. Steins +5 more
2006International Journal of Cancer20 citations Open access
Semantic Scholar
Paclitaxel for treatment of advanced small cell lung cancer (SCLC): a retrospective study of 185 patients
D. von Eiff, F. Bozorgmehr, I. Chung, D. Bernhardt +7 more
2020Journal of Thoracic Disease19 citations Open access
Semantic Scholar
Generation of a New Disease‐specific Prognostic Score for Patients With Brain Metastases From Small‐cell Lung Cancer Treated With Whole Brain Radiotherapy (BMS‐Score) and Validation of Two Other Indices
D. Bernhardt, L. König, Sophie Aufderstrasse, J. Krisam +14 more
2017Clinical Lung Cancer19 citations
Semantic Scholar
1301PDThree-year follow-up from CheckMate 017/057: Nivolumab versus docetaxel in patients with previously treated advanced non-small cell lung cancer (NSCLC)
E. Font, S. Gettinger, M. Burgio, S. Antonia +16 more
201719 citations Open access
Semantic Scholar
Targeting the Epidermal Growth Factor Receptor in Non-Small Cell Lung Cancer
M. Steins, N. Reinmuth, H. Bischoff, Markus Kindermann +1 more
2010Oncology Research and Treatment15 citations
Semantic Scholar
Nine‐year Experience: Prophylactic Cranial Irradiation in Extensive Disease Small‐cell Lung Cancer
D. Bernhardt, S. Adeberg, F. Bozorgmehr, Nils Opfermann +10 more
2017Clinical Lung Cancer14 citations
Semantic Scholar
Exercise behavior and physical fitness in patients with advanced lung cancer
C. Titz, S. Hummler, M. Schmidt, Michael Thomas +2 more
2018Supportive Care in Cancer13 citations
Semantic Scholar
417OPhase 3, randomized trial (CheckMate 057) of nivolumab vs docetaxel in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): subgroup analyses and patient reported outcomes (PROs)
L. Horn, J. Brahmer, M. Reck, H. Borghaei +16 more
201512 citations Open access
Semantic Scholar
CT characteristics in pulmonary adenocarcinoma with epidermal growth factor receptor mutation
Jing Zhao, J. Dinkel, A. Warth, R. Penzel +12 more
2017PLoS ONE11 citations Open access
Semantic Scholar
Assessment of thymidylate synthase expression in biopsy specimens and corresponding resection specimens of non‐small‐cell lung cancer
E. Herpel, P. Schnabel, M. Steins, H. Dienemann +4 more
2012Histopathology10 citations
Semantic Scholar
Outcome and prognostic factors of postoperative radiation therapy (PORT) after incomplete resection of non-small cell lung cancer (NSCLC).
J. Rieber, Alexander Deeg, E. Ullrich, R. Foerster +13 more
2016Lung Cancer8 citations
Semantic Scholar
3010 Phase, randomized trial (CheckMate 057) of nivolumab (NIVO) vs docetaxel (DOC) in advanced non-squamous (non-SQ) non-small cell lung cancer (NSCLC): Subgroup analyses and patient reported outcomes (PROs)
L. Horn, J. Brahmer, M. Reck, H. Borghaei +16 more
20157 citations
Semantic Scholar
Randomized phase 3 trial of amrubicin versus topotecan as second-line treatment for small cell lung cancer (SCLC)
J. von Pawel, R. Jotte, Spigel, M. Socinski +16 more
20126 citations
Semantic Scholar
Brown France vs. Black Africa: the tide turned in 1932
M. Steins
19835 citations
Semantic Scholar
Feasibility of cetuximab in combination with gemcitabine or docetaxel or carboplatin/gemcitabine for chemonaive patients with advanced non-small cell lung cancer (NSCLC): Observations from an ongoing randomized phase II/III trial (GemTax IV)
L. Pilz, S. Cicėnas, C. Eschbach, J. Fischer +5 more
20083 citations
Semantic Scholar
Retrospective study of paclitaxel in advanced therapy lines in the treatment of SCLC.
D. von Eiff, F. Bozorgmehr, P. Christopoulos, I. Chung +7 more
2018Annals of Oncology2 citations Open access
Semantic Scholar
Effects of physical exercise in non-operable lung cancer patients undergoing palliative treatment.
J. Wiskemann, C. Titz, M. Schmidt, K. Steindorf +7 more
2018Annals of Oncology2 citations Open access
Semantic Scholar
Schmerztherapie in der Palliativmedizin
M. Steins, Corinna Eschbach, M. Villalobos, Michael Thomas
2017Pneumologie2 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

Michael Thomas×17
Invite
Michael Thomas — researcher profile on SciRah
D. Spigel×14
Invite
D. Spigel — researcher profile on SciRah
L. Horn×13
Invite
L. Horn — researcher profile on SciRah
M. Reck×13
Invite
M. Reck — researcher profile on SciRah

×13

Invite

C. Heussel — researcher profile on SciRah

L. Paz-Ares×12

Invite

L. Paz-Ares — researcher profile on SciRah

Invite

N. Ready — researcher profile on SciRah

Invite

J. Brahmer — researcher profile on SciRah

Invite

S. Rieken — researcher profile on SciRah

H. Borghaei×10

Invite

H. Borghaei — researcher profile on SciRah

Invite

F. Barlesi — researcher profile on SciRah

Invite

J. Kappes — researcher profile on SciRah